Financhill
Back

Mayne Pharma Group Ltd. 10K Form

Sell
28

MAYNF
Mayne Pharma Group Ltd.

Last Price:
$2.36
Seasonality Move:
-4.45%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MAYNF News And Ratings

See the #1 stock for the next 7 days that we like better than MAYNF

MAYNF Financial Statistics

Sales & Book Value

Annual Sales: $264.3M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $3.42
Price / Book: 0.96

Profitability

EPS (TTM): -0.76350
Net Income (TTM): $-57.7M
Gross Margin: $120.6M
Return on Equity: -26.72%
Return on Assets: -11.32%

Mayne Pharma Group Ltd. Earnings Forecast

Key Mayne Pharma Group Ltd. Financial Ratios

  • The Gross Profit Margin over the past 16 years for MAYNF is 45.64%.
  • The Selling, General & Administrative Expenses for MAYNF have been equal to 33.53% of Gross Profit Margin.
  • The Research & Development expenses have been 4.39% of Revenue.
  • The Net Earning history of MAYNF is -22.07% of Total Revenues.
  • Per Share Earnings over the last 19 years have been positive in 10 years.

Mayne Pharma Group Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: MAYNF
Website: maynepharma.com

Debt

Debt-to-Equity Ratio: 0.09
Current Ratio: 1.4
Quick Ratio: 1.06

Price-to-Earnings

Trailing P/E Ratio: 4.7
Forward P/E Ratio: 0

MAYNF Technical Analysis vs Fundamental Analysis

Sell
28
Mayne Pharma Group Ltd. (MAYNF) is a Sell

Is Mayne Pharma Group Ltd. a Buy or a Sell?